Elston George 4
4 · EyePoint Pharmaceuticals, Inc. · Filed May 27, 2025
Insider Transaction Report
Form 4
Elston George
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-05-25$5.68/sh−2,202$12,507→ 80,848 total - Exercise/Conversion
Restricted Stock Units
2025-05-25−7,500→ 7,500 totalExercise: $0.00→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2025-05-25+7,500→ 83,050 total
Footnotes (2)
- [F1]No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units.
- [F2]The restricted stock units vest in three ratable annual installments beginning May 25, 2024.